Mills Kenneth T.
CIK 0001652824
President and CEODirector
Filings
17
Latest Jun 2, 2026
Issuers covered
1
Showing
17 of 17
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 67% | +0.4% | +9.2% | +29.8% | -32.2% |
| 90 days | 12 | 83% | +15.7% | +23.4% | +39.8% | -18.0% |
| 180 days | 12 | 92% | +31.7% | +42.0% | +48.7% | -38.3% |
| 365 days | 12 | 92% | +43.2% | +49.3% | +69.2% | -28.5% |
Issuers
Companies where Mills Kenneth T. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RGNX | Regenxbio Inc. | 17 | Jun 2, 2026 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|